Results 111 to 120 of about 215,114 (209)

Sex work or male-with-male sexual activity and the risks of HIV and hepatitis C acquisition among people who inject drugs: a global systematic review and meta-analysis. [PDF]

EClinicalMedicine
Dawe J, Trickey A, Walker J, Barrass L, Njiro BJ, Kundu B, Hickman M, Abramovitz D, Aladashvili M, Artamonova I, Blouin K, Boyd A, Bruneau J, DeBeck K, Jarlais DD, Dietze P, Dumchev K, Hankins C, Hatzakis A, Havens JR, Hope V, Hayashi K, Jongen V, Kurth A, Maher L, Mehta S, Mitchell H, Morris MD, Page K, Palmateer NE, Platt L, Prins M, Rathnayake K, Saraswati LR, Roussos S, Sacks-Davis R, Sarna A, Solomon S, Strathdee SA, Sypsa V, Van Santen D, Zang G, Stone J, Vickerman P, Artenie AA.   +44 more
europepmc   +1 more source

Characteristics of an antibody profile associated with protection against hepatitis C virus reinfection in a high-risk cohort. [PDF]

Gut
Chumbe AL, van den Aardweg SMD, Boyd A, Grobben M, Koekkoek SM, Zon I, Prins M, Sliepen K, van Gils MJ, Schinkel J.   +9 more
europepmc   +1 more source

Catch me if you can! Is there protection from HCV (re)infection? [PDF]

Gut
Bartosch B, Lauer GM.
europepmc   +1 more source

Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication” [PDF]

Clinical and Molecular Hepatology
Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu   +3 more
doaj   +1 more source

Modeling Predicts Direct-Acting Antiviral Therapy for 5-Weeks May Cure Recent or Chronic Hepatitis C Infection Among People With Undetectable Viral RNA by Day 7. [PDF]

J Infect Dis
Goyal A, Cotler SJ, Matthews GV, Page K, Kushner T, Etzion O, Martinello M, Dahari H.   +7 more
europepmc   +1 more source

Transition From Interferon-Based Therapy to Direct-Acting Antivirals in Albanian Children With Chronic Hepatitis C: A 17-Year Real-World Experience. [PDF]

Adv Virol
Velmishi V, Dervishi E, Hoxha G, Saraci B, Bali D, Xhafa M, Kapllanaj M, Duka E, Shundi L, Cullufi P.   +9 more
europepmc   +1 more source

A cross-sectional study on the relationship between hepatitis C virus infection and the risk of sleep disorders among adults based on NHANES data from 2017 to 2020: A cross-sectional study. [PDF]

Medicine (Baltimore)
Li J, Wu Q.
europepmc   +1 more source

Progress Towards Eliminating Hepatitis C as a Public Health Threat in Norway. [PDF]

J Viral Hepat
Whittaker R, Wüsthoff LC, Midtbø JE, Midgard H, Dalgard O.   +4 more
europepmc   +1 more source

Microelimination of hepatitis C in dialysis units: results from the Brazilian Registry for the elimination of HCV. [PDF]

J Bras Nefrol
Abreu PF, Alves PRC, Bittencourt PL, Calvo ICS, Vieira Neto OM, Nascimento MMD, Neves FC, Moura AF, Calazans DCC, Salcedo JMV, Rocha CM, Lobato CMO, França AVC, Pierre AMM, Ferreira ASP, Lopes EP, Medeiros Filho JEM, Souto FJD, Aires RS, Mendes LSC, Uehara SNO, Gonçalves LL, Carmo LPFD, Ivantes CAP, Cheinquer H, Parreira TB, Israel KCSP, Costa VJRC, Sousa HDC, Nasserala JCL, Bastos KA, Pinheiro ME, Silva AQBD, Oliveira CMC, Barros FHS, Dourado MMC, Costa CB, Mothé RA, Cabral AS, Simão DR, Barreto FC, Fraxino PH, Constancio NS, Silva DRD, Silva Filho ÁP, Moura LRR, Machado DJB, Brabo AM, Naseri AP, Carvalho TR, Pestana NDF, Rocha PTMCEA, Lima LMSTB, Perez RM, Narciso-Schiavon JL, Andrade ARCF, Zawadzki B, Moura-Neto JA, Ferraz MLG.   +58 more
europepmc   +1 more source

Estimating the Fraction of Hepatocellular Carcinoma and Decompensated Cirrhosis Attributable to Viral Hepatitis in England Using Electronic Health Records and Case-Notes Review. [PDF]

J Viral Hepat
Etoori D, Powell A, Trembling P, Plunkett J, Brown A, Lemoine M, Ryder S, Montague S, Pilsworth E, Bains A, Harrison L, Pavlides M, Elsharkawy A, Sabin C, Desai M, Simmons R.   +15 more
europepmc   +1 more source